BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37074548)

  • 1. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
    McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
    Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa.
    Keyter A; Salek S; McAuslane N; Banoo S; Azatyan S; Walker S
    Ther Innov Regul Sci; 2020 Sep; 54(5):1199-1207. PubMed ID: 32865802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
    Shabangu PP; Kuwana RJ; Dube A
    Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
    Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
    Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliance: a smarter way of regulating medical products - The IPRP survey.
    Doerr P; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):173-177. PubMed ID: 33355025
    [No Abstract]   [Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
    Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
    Ncube BM; Dube A; Ward K
    Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
    Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
    Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
    [No Abstract]   [Full Text] [Related]  

  • 12. The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System.
    Keyter A; Gouws J; Salek S; Walker S
    Ther Innov Regul Sci; 2018 Jul; 52(4):449-458. PubMed ID: 29848046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
    Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
    Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
    Ncube BM; Dube A; Ward K
    Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
    Ncube BM; Dube A; Ward K
    Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
    Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
    Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
    Narsai K; Williams A; Mantel-Teeuwisse AK
    South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.